Off-Pump Bypass Shows No Clear Overall Advantage in Frail Older Adults
In 508 older adults with frailty, bypass techniques showed no significant difference in major complications, but off-pump surgery had fewer infections.
Summary
Does avoiding a heart-lung machine make bypass surgery safer for older adults with frailty? The FRAGILE trial randomly assigned 508 prefrail or frail adults aged 60 or older to off-pump or on-pump surgery. Within 30 days, death or major complications occurred in 10.9% versus 16.0%, respectively, but the difference was not statistically significant. Wound infections were less common after off-pump surgery: 3.5% versus 8.0%. Estimated survival at one year was 96.1% versus 92.8%, also without a statistically significant difference. Thinking skills and quality of life did not differ significantly at one year. The findings do not establish that either technique is better overall or that they are equivalent. Patients should discuss the options with their surgical team. This summary is based on the abstract only.
Detailed Summary
Frailty makes heart bypass surgery riskier, raising questions about whether avoiding a heart-lung machine improves recovery. For older adults with reduced physical reserves, choosing the safest surgical approach could help protect survival, thinking skills, and independence. The FRAGILE trial directly compared two established bypass techniques in this vulnerable population.
Researchers randomly assigned 508 prefrail or frail adults aged 60 or older to surgery with or without a heart-lung machine across multiple centers. Median age was 68 years, and 30.5% were women. The main outcome combined death, heart attack, stroke, kidney failure, severe respiratory failure, or repeat surgery for bleeding within 30 days.
That outcome occurred in 10.9% of patients undergoing off-pump surgery and 16.0% undergoing on-pump surgery. Although numerically lower without the machine, the difference did not reach statistical significance. Surgical wound infections occurred in 3.5% versus 8.0%, respectively, a statistically significant difference. Estimated survival at one year was 96.1% versus 92.8%, but this difference also was not statistically significant.
Neither approach showed a significant advantage in thinking skills or quality of life at one year. These findings do not establish that either technique is superior overall. For patients and clinicians, they support discussing surgical options individually rather than assuming that avoiding the machine necessarily improves major outcomes. The infection finding deserves attention, but it was a secondary outcome.
This summary is based on the abstract only; detailed methods and complete results were unavailable. The trial was open-label, and the abstract does not describe frailty assessment, surgeon experience, or adjustment for testing multiple outcomes. Nonsignificant results do not prove equivalence or exclude meaningful differences. Follow-up of one year cannot establish longer-term effects on survival, independence, or bypass durability. Applicability to younger, nonfrail patients or different surgical settings remains uncertain. Individual decisions should still consider anatomy, overall health, and surgical expertise.
Key Findings
- Among 508 prefrail or frail adults, 30-day death or major complications occurred in 10.9% after off-pump versus 16.0% after on-pump surgery.
- The primary outcome difference was not statistically significant (P=0.09), so the trial did not establish superiority.
- Wound infections occurred in 3.5% after off-pump versus 8.0% after on-pump surgery (P=0.04), a secondary finding requiring cautious interpretation.
- Estimated one-year survival was 96.1% versus 92.8%, respectively; the difference was not statistically significant.
- Thinking skills and quality of life did not differ significantly at one year; surgical choices should remain individualized.
Methodology
FRAGILE was a multicenter, randomized, open-label trial enrolling prefrail or frail adults aged 60 or older between January 2018 and December 2024. Participants received off-pump surgery (258) or on-pump surgery (250), with intention-to-treat analysis of a prespecified 30-day composite outcome and additional outcomes through one year.
Study Limitations
This summary is based on the abstract only; detailed methods, individual complication rates, and information about adjustment for multiple comparisons were unavailable. The open-label design and secondary status of the infection finding warrant caution, while nonsignificant differences do not establish equivalence. One-year follow-up does not resolve longer-term survival or bypass durability.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
